+1 year(s) experience
Through her projects, Karolina gained expertise on a wide variety of markets, ranging from blockbuster drugs, such as pneumococcal vaccines, to neglected tropical diseases like dengue fever.
She specializes in infectious disease vaccines, including vaccines for pneumococcal and meningococcal diseases, respiratory syncytial virus (RSV), and dengue fever. She also covers certain immunology & inflammation diseases, such as systemic lupus erythematosus (SLE), as well as select metabolic indications.
Before joining Informa in 2017, Karolina completed a degree in Biomedical Sciences, focused on infectious diseases and cell biology, at Univeristy College London and a Masters in Pharmaceutical Economics at the London School of Economics.
By Karolina Kujawa 28 Aug 2018
Over 1.2 million cases of bacterial meningitis are estimated to occur worldwide each year. If not treated promptly, up to half of those cases will be fatal. This infographic from Datamonitor Healthcare provides a snapshot of the meningococcal vaccines market in the US and five major EU markets. What does the meningococcal vaccines market have in store and how will it affect your business? Download now.